Selected article for: "cross sectional study and respiratory symptom"

Author: Matteo, Tosato; Angelo, Carfì; Ilaria, Martis; Pais, Cristina; Francesca, Ciciarello; Elisabetta, Rota; Marcello, Tritto; Andrea, Salerno; Beatrice, Zazzara Maria; Maria, Martone Anna; Annamaria, Paglionico; Luca, Petricca; Vincenzo, Brandi; Gennaro, Capalbo; Anna, Picca; Riccardo, Calvani; Emanuele, Marzetti; Francesco, Landi
Title: PREVALENCE AND PREDICTORS OF PERSISTENCE OF COVID-19 SYMPTOMS IN OLDER ADULTS: A SINGLE-CENTER STUDY
  • Cord-id: bw16s2h6
  • Document date: 2021_7_19
  • ID: bw16s2h6
    Snippet: Objectives Symptom persistence weeks after laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) clearance is a relatively common long-term complication of Coronavirus disease 2019 (COVID-19). Little is known about this phenomenon in older adults. The present study aimed at determining the prevalence of persistent symptoms among old COVID-19 survivors and identifying symptom patterns. Design Cross-sectional study. Setting and Participants We analyzed data collected in
    Document: Objectives Symptom persistence weeks after laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) clearance is a relatively common long-term complication of Coronavirus disease 2019 (COVID-19). Little is known about this phenomenon in older adults. The present study aimed at determining the prevalence of persistent symptoms among old COVID-19 survivors and identifying symptom patterns. Design Cross-sectional study. Setting and Participants We analyzed data collected in people 65 years and older (n=165) who were hospitalized for COVID-19 and then admitted to the Day Hospital Post-COVID 19 of the XXX between April and December 2020. All patients tested negative for SARS-CoV-2 and met the World Health Organization criteria for quarantine discontinuation. Measures Patients were offered multidisciplinary individualized assessments. The persistence of symptoms was evaluated on admission using a standardized questionnaire. Results The mean age was 73.1 ± 6.2 years (median 72, interquartile range 27), and 63 (38.4%) were women. The average time elapsed from hospital discharge was 76.8 ± 20.3 days (range 25−109 days). On admission, 137 (83%) patients reported at least 1 persistent symptom. Of these, over one third reported 1 or 2 symptoms and 46.3% had 3 or more symptoms. The rate of symptom persistence was not significantly different when patients were stratified according to median age. Compared with those with no persistent symptoms, patients with symptom persistence reported a greater number of symptoms during acute COVID-19 (5.3 ± 3.0 vs. 3.3 ± 2.0; p<0.001). The most commonly persistent symptoms were fatigue (53.1%), dyspnea (51.5%), joint pain (22.2%), and cough (16.7%). The likelihood of symptom persistence was higher in those who had experienced fatigue during acute COVID-19. Conclusions and implications Persistent symptoms are frequently experienced by older adults who have been hospitalized for COVID-19. Follow-up programs should be implemented to monitor and care for long-term COVID-19-related health issues.

    Search related documents:
    Co phrase search for related documents
    • acute phase and long term illness: 1
    • acute respiratory syndrome and long term illness: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute syndrome and long term illness: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10